COVID-19 Guidance

 

Emory IRB Guidance: Resuming In-Person Research Activities

Whether your study was temporarily on hold, or is newly starting up, the below guidance outlines the safety measures required for different kinds of in-person study activities, and if and when IRB modifications are required to resume these activities.

Emory IRB COVID-19 Ramp-Up Guidance

 Addressed in the above Guidance:

  • What PPE and other safety measures are needed to resume non-essential in-person research activities?
  • How can I request an exception to the guidelines?

 

Emory IRB Guidance: Managing Research during Covid Pandemic

In this unusual circumstance of a pandemic illness, it may be necessary to urgently modify research study procedures. New protocols may also need prioritized IRB review.

Emory IRB Guidance for Managing Research during Covid-19

Addressed in the above Guidance:

  • When and how must the Emory IRB be notified of changes to approved research?
  • When may prior Emory IRB approval not be needed?
  • How quickly can the IRB review new COVID-19 protocols?
  • Will Emory IRB’s review capacity be impacted due to Emory’s closures?
  • What are my Informed Consent options (electronic and other)?
  • What if we experience a decrease in the workforce?
  • What if I need to request an expanded access use for patient treatment?
  • Links to additional resources
  • Example of a Screening Log

     

NEW 8/23/2020: FDA issues Emergency Use Authorization for Convalescent Plasma

Important: You must provide the FDA-provided "fact sheets" to patients/care givers and medical providers.

Other Relevant Emory IRB Guidance

Other Guidance and Resources